Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

ClinicalTrials.gov ID: NCT03377491

Public ClinicalTrials.gov record NCT03377491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Brief Summary: The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFields) in combination with gemcitabine and nab-paclitaxel, for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.

Study identification

NCT ID
NCT03377491
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NovoCure Ltd.
Industry
Enrollment
571 participants

Conditions and interventions

Interventions

Device · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 10, 2018 (Actual)
Primary completion
Oct 16, 2024 (Actual)
Completion
Oct 16, 2024 (Actual)
Last update posted
Jan 21, 2026

2018 – 2024

United States locations

U.S. sites
74
U.S. states
30
U.S. cities
69
Facility City State ZIP Site status
Grandview Medical Center, Cancer Center Birmingham Alabama 35243 —
Infirmary Cancer Care Mobile Alabama 36607 —
Banner MD Anderson Cancer Center Gilbert Arizona 85234 —
Arizona Oncology Associates, PC- HOPE - US Oncology Research Tucson Arizona 85711 —
University of Arizona Cancer Center Tucson Arizona 85724-5024 —
Pacific Cancer Medical Center Anaheim California 92801 —
Providence Medical Foundation Fullerton California 92835 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Dignity Health - Mercy Cancer Centers Sacramento California 95816 —
Sutter Cancer Center Sacramento Sacramento California 95816 —
Ridley-Tree Cancer Center Santa Barbara California 93105 —
Adventist Health St. Helena - Martin-O'Neil Cancer Center (MOCC) St. Helena California 94574 —
Associated Neurologists of Southern Connecticut, P.C. Milford Connecticut 06460 —
Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton Florida 33486 —
Cancer Specialist of North Florida Fleming Island Florida 32003 —
Florida Cancer Specialists & Research Institute - Colonial Office Fort Myers Florida 33905 —
Mayo Clinic Hospital - Florida Jacksonville Florida 32224 —
Mount Sinai Medical Center Miami Beach Florida 33140 —
AdventHealth Neuro Oncology Orlando Florida 32804 —
BRCR Medical Center INC Plantation Florida 33324 —
Florida Cancer Specialists St. Petersburg Florida 33705 —
Florida Hospital Tampa Tampa Florida 33613 —
Piedmont Cancer Institute Atlanta Georgia 30318 —
Illinois Cancer Specialist - US Oncology Research Arlington Heights Illinois 60005 —
Rush University Medical Center Chicago Illinois 60612 —
NorthShore University HealthSystem Evanston Illinois 60201 —
Loyola University Medical Center Maywood Illinois 60153 —
University of Kansas Medical Cancer Center Fairway Kansas 66205 —
Cotton O'Neil Cancer Center (Stormont-Vail Cancer Center) Topeka Kansas 66606 —
Saint Elizabeth Healthcare Edgewood Kentucky 41017 —
Norton Cancer Institute, Norton Healthcare Pavilion Louisville Kentucky 40202 —
Ochsner Medical Center New Orleans Louisiana 70121 —
Central Maine Medical Center, Clinical Research Department Lewiston Maine 04240 —
University of Maryland Comprehensive Cancer Center Baltimore Maryland 21201 —
Maryland Oncology Hematology, P.A - US Oncology Research Columbia Maryland 21044 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
UMass Memorial Medical Center Worcester Massachusetts 01605 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Cancer and Hematology Centers of Western Michigan, PC Grand Rapids Michigan 49503 —
University of Minnesota Minneapolis Minnesota 55455 —
MidAmerica Division Kansas City Missouri 64132 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
OptumCare Cancer Care Las Vegas Nevada 89102 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89619 —
Renown Regional Medical Center & Renown Institute for Cancer Reno Nevada 89502 —
Astera Cancer Care East Brunswick New Jersey 08816 —
Kaleida Health Buffalo New York 14210 —
Bassett Medical Center Cooperstown New York 13326 —
New York Hospital Queens Flushing New York 11355 —
NYU Langone Arena Oncology Lake Success New York 11042 —
White Plains Hospital - Center for Cancer Care White Plains New York 10601 —
Novant Health Oncology Specialists Winston-Salem North Carolina 27103 —
Gabrail Cancer Research Center Canton Ohio 44718 —
Toledo Clinic Cancer Centers Toledo Ohio 44614 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Willamette Valley Cancer Institute and Research Center - US Oncology Research Eugene Oregon 97401 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Vita Medical Associates, P.C. Fountain Hill Pennsylvania 18015 —
UT/Erlanger Oncology & Hematology Chattanooga Tennessee 37403 —
Tennessee Cancer Specialists Knoxville Tennessee 37909-1327 —
Tennessee Oncology Nashville Tennessee 37203 —
Texas Oncology - Beaumont Mamie McFaddin Ward Cancer Center - US Oncology Research Beaumont Texas 77702 —
Texas Oncology - Bedford - US Oncology Reasearch Bedford Texas 76022 —
Methodist Regional Cancer Center Dallas Texas 75203 —
Texas Oncology - Baylor - US Oncology Research Dallas Texas 75246 —
Texas Oncology - El Paso Cancer Treatment Center Gateway - US Oncology Research El Paso Texas 79915 —
Houston Methodist Cancer Center Houston Texas 77030 —
Baylor Scott and White Medical Center Temple Texas 76508 —
Texas Oncology - Tyler - US Oncology Research Tyler Texas 75702 —
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care - US Oncology Research Roanoke Virginia 24014 —
Vista Oncology Inc PS Olympia Washington 98506 —
Virginia Mason Medical Center Seattle Washington 98101 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
West Virginia University Cancer Institute Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 125 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03377491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03377491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →